News

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...
Yesterday, the US Court of Appeals for the Federal Circuit said scientists Jennifer Doudna and Emmanuelle Charpentier will ...
Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year moratorium on ...
An appeals court has opened another chapter in the long-running CRISPR patent saga. | An appeals court has opened another ...
CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
A federal appeals court said the patent office made legal errors in awarding foundational patents for CRISPR-Cas9 to the ...
The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR ...
In this Revvity GENCast episode 2, experts will discuss applications of gene editing to improve scientists’ understanding of the relationship between variant and disease in functional genomics studies ...
In a precedential opinion issued on Monday, the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated and remanded a ...
The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 ...
Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...
PIC's gene-edited pigs are highly resistant to one of the most harmful viruses affecting pig populations worldwide today.